Allegiant Travel Company (NASDAQ:ALGT – Get Free Report) Director Charles Pollard sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $93.04, for a total value of $930,400.00. Following the sale, the director directly owned 16,000 shares in the company, […]

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director Jason Aryeh sold 1,411 shares of the firm’s stock in a transaction that occurred on Friday, October 30th. The stock was sold at an average price of $320.24, for a total transaction of $451,858.64. Following the sale, the director owned 109,458 shares in the company, valued […]

CME Group Inc. (NASDAQ:CME – Get Free Report) Director Howard Siegel sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $303.00, for a total value of $606,000.00. Following the completion of the sale, the director directly owned 19,873 shares […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Kathryn Guarini sold 400 shares of the firm’s stock in a transaction that occurred on Friday, October 30th. The stock was sold at an average price of $900.00, for a total transaction of $360,000.00. Following the transaction, the director directly owned 603 shares of the company’s […]